EP3416654
LÆKNISFRÆÐILEG NOTKUN 5'ADENÓSÍNTVÍFOSFAT RÍBÓSA (ADPR)
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
17.2.2017EP published:
27.10.2021EP application number:
17708104.9
EP translation filed:
15.12.2021Grant published:
15.1.2022EPO information:
European Patent Register
Max expiry date:
16.2.2037Expiry date:
16.2.2027Next due date:
28.2.2027
Title:
MEDICAL USE OF 5'-ADENOSINE DIPHOSPHATE RIBOSE (ADPR)
Timeline
Today
17.2.2017EP application
27.10.2021EP Publication
15.12.2021Translation submitted
15.1.2022Registration published
16.2.2027Expires
Owner
Name:
Invirsa, Inc.Address:
1275 Kinnear Road, Columbus OH 43212, US
Inventor
Name:
SHALWITZ, RobertAddress:
Bexley OH 43209, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201662296665 PDate:
18.2.2016Country:
US
Number:
201662428721 PDate:
1.12.2016Country:
US
Classification
Categories:
A61K 31/7076, A61K 31/522, A61K 31/675, A61K 33/24, A61K 45/06, C07H 19/20, A61P 31/20, A61P 35/00, A61P 27/02, A61P 11/00, A61P 29/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 24.1.2022
Expires: 16.2.2023
Payer: Árnason Faktor ehf.
Number: 7
Paid: 10.2.2023
Expires: 16.2.2024
Payer: G.H. Sigurgeirsson ehf.
Number: 7
Paid: 10.2.2023
Expires: 16.2.2024
Payer: G.H. Sigurgeirsson ehf.
Number: 8
Paid: 12.2.2024
Expires: 16.2.2025
Payer: G.H. Sigurgeirsson ehf.
Number: 9
Paid: 11.2.2025
Expires: 16.2.2026
Payer: G.H. Sigurgeirsson ehf.
Number: 10
Paid: 16.2.2026
Expires: 16.2.2027
Payer: G.H. Sigurgeirsson ehf.